H.C. Wainwright Reiterates Buy Rating on Olema Pharmaceuticals (OLMA)

May 22, 2026 6:54 AM

H.C. Wainwright analyst Emily Bodnar reiterated a Buy rating and $38.00 price target on Olema Pharmaceuticals (NASDAQ: OLMA).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found